Your browser doesn't support javascript.
Communicating Effectively About Emergency Use Authorization and Vaccines in the COVID-19 Pandemic.
Quinn, Sandra Crouse; Jamison, Amelia M; Freimuth, Vicki.
  • Quinn SC; Sandra Crouse Quinn is with the Department of Family Science and the Maryland Center for Health Equity, School of Public Health, University of Maryland, College Park. Amelia M. Jamison is with the Maryland Center for Health Equity, School of Public Health, University of Maryland. Vicki Freimuth is with Center for Health and Risk Communication (Emeritus), University of Georgia, Athens.
  • Jamison AM; Sandra Crouse Quinn is with the Department of Family Science and the Maryland Center for Health Equity, School of Public Health, University of Maryland, College Park. Amelia M. Jamison is with the Maryland Center for Health Equity, School of Public Health, University of Maryland. Vicki Freimuth is with Center for Health and Risk Communication (Emeritus), University of Georgia, Athens.
  • Freimuth V; Sandra Crouse Quinn is with the Department of Family Science and the Maryland Center for Health Equity, School of Public Health, University of Maryland, College Park. Amelia M. Jamison is with the Maryland Center for Health Equity, School of Public Health, University of Maryland. Vicki Freimuth is with Center for Health and Risk Communication (Emeritus), University of Georgia, Athens.
Am J Public Health ; 111(3): 355-358, 2021 03.
Article in English | MEDLINE | ID: covidwho-1083498

Full text: Available Collection: International databases Database: MEDLINE Main subject: United States Food and Drug Administration / Health Communication / COVID-19 Vaccines / COVID-19 Type of study: Experimental Studies / Observational study Topics: Vaccines Limits: Humans Country/Region as subject: North America Language: English Journal: Am J Public Health Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: United States Food and Drug Administration / Health Communication / COVID-19 Vaccines / COVID-19 Type of study: Experimental Studies / Observational study Topics: Vaccines Limits: Humans Country/Region as subject: North America Language: English Journal: Am J Public Health Year: 2021 Document Type: Article